TheEdgeResearch
Home / Stocks / LDDD

Longduoduo Company Limited (LDDD)

OTC Healthcare Medical - Diagnostics & Research
$0.51 ▲ +0.00%
Market Cap
$15.3M
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.09
52-Wk Range
0.51-0.5933
CEO
Hongxiao Zhou
Country
CN
Currency
USD

Longduoduo Company Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Hohhot, MO, CN. The stock last traded at $0.51, up 0.00% on the session, giving a market capitalisation of $15.3M. On trailing twelve-month figures it carries a trailing P/E of -16.56, a net margin of -78.3%. Its beta of 1.09 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-16.56
Price / Sales
12.96
Price / Book
53.13
EV / EBITDA
-15.57
Gross margin
94.4%
Operating margin
-88.5%
Net margin
-78.3%
Return on equity
—
Debt / equity
0.17
Current ratio
1.07
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
51
IPO date
2023-01-18
Headquarters
Hohhot, MO, CN
About Longduoduo Company Limited

Longduoduo Company Limited, along with its associated entities, operates within the People's Republic of China, focusing on providing proactive health management and preventative medical services. The company's comprehensive suite of offerings includes health screenings, diverse treatment options, and specialized healthcare products, all aimed at reducing the likelihood of severe conditions such as myocardial infarction (heart attacks), cerebral infarction (strokes), hemiplegia (paralysis), and other cardiovascular and cerebrovascular diseases. These services are delivered through an extensive network of external collaborators, including independent healthcare providers, product vendors, and sales representatives. Additionally, Longduoduo features a range of advanced therapeutic interventions. These encompass meridian-regulating and consciousness-restoring techniques, a double blood purification process, immunological ozonated autohemotherapy, platelet-rich plasma therapy, relaxation techniques, vegetative nerve regulation, and microwave therapy. Established in 2020, the firm's primary operational base is located in Hohhot, China.

Comparable companies

Longduoduo Company Limited is most often compared with the following Healthcare names:

CHMECPHIKPEAUPCYIZHYBF
More research on LDDD
LDDD technical analysis LDDD TheEdge Score Compare against peers
Open full interactive analysis & DCF →